“Antitransglutaminase” antibodies are seen in:
**Core Concept**
Antitransglutaminase antibodies are a type of autoantibody that targets tissue transglutaminase, an enzyme involved in protein cross-linking and modification. The presence of these antibodies is a hallmark of celiac disease, an autoimmune disorder triggered by gluten ingestion.
**Why the Correct Answer is Right**
The formation of antitransglutaminase antibodies is believed to be an immune response to the ingestion of gluten in genetically predisposed individuals. This leads to the activation of T cells and the production of autoantibodies against tissue transglutaminase, resulting in small intestine damage and malabsorption. The antibodies are directed against the enzyme's active site, inhibiting its activity and contributing to the pathogenesis of celiac disease.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because antitransglutaminase antibodies are not typically associated with rheumatoid arthritis, which is characterized by the presence of rheumatoid factor and anti-citrullinated protein antibodies.
**Option B:** This option is incorrect because antineutrophil cytoplasmic antibodies (ANCA) are associated with vasculitides such as granulomatosis with polyangiitis and microscopic polyangiitis, rather than celiac disease.
**Option C:** This option is incorrect because antistreptolysin O titer is a measure of immunity to group A beta-hemolytic streptococci and is not related to the presence of antitransglutaminase antibodies.
**Clinical Pearl / High-Yield Fact**
Celiac disease is a classic example of an autoimmune disorder triggered by environmental factors (gluten ingestion) in genetically predisposed individuals. It is essential to consider celiac disease in the differential diagnosis of patients presenting with chronic diarrhea, malabsorption, or unexplained weight loss.
**Correct Answer:** C. Celiac disease.